Facebook
Twitter
LinkedIn
ForwardPulse: Breathe In With The Old, Breathe Out With The New: PRN SABA vs ICS-LABA_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
The GINA guidelines for treatment of Asthma were updated in 2020 discouraging use of PRN SABA therapy alone for exacerbations and now recommends using a low-dose ICS/formoterol agent. These updates were sponsored by the company AstraZeneca who is the producer of the medication inhaler Symbicort (budesonide/formoterol). This presentation will review the current literature supporting the use of ICS/LABA vs SABA PRN as well provide the tools for pharmacists to make an informed decision on appropriate asthma therapy regimens.
Target Audience
Pharmacist
Learning Objectives
1. List the current guideline recommended therapies.
2. Review current literature comparing efficacy and safety of as-needed albuterol vs low-dose ICS/formoterol for asthma symptom control.
3. Discuss guideline controversy and clinical application
Additional Information
| Attachment | Size |
|---|---|
 Disclosure Slides_Slaven.pdf | 289.16 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
The GINA guidelines for treatment of Asthma were updated in 2020 discouraging use of PRN SABA therapy alone for exacerbations and now recommends using a low-dose ICS/formoterol agent. These updates were sponsored by the company AstraZeneca who is the producer of the medication inhaler Symbicort (budesonide/formoterol). This presentation will review the current literature supporting the use of ICS/LABA vs SABA PRN as well provide the tools for pharmacists to make an informed decision on appropriate asthma therapy regimens.
Brianne Slaven, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.